HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes
Clinical trial NCT04396626 · TERMINATED
Trial details
- NCT number
- NCT04396626
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-18
- Primary completion
- 2020-05-31
- Enrollment
- 975
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.